Targeting CD123 in Hematologic Malignancies: Identifying Suitable Patients for Targeted Therapy

Scientists review the methodologies available for CD123 assessment and discuss the biological and clinical characteristics of patients for whom CD123-targeting therapies may have a clinical impact.